GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Konruns Pharmaceutical Co Ltd (SHSE:603590) » Definitions » Ending Cash Position

Beijing Konruns Pharmaceutical Co (SHSE:603590) Ending Cash Position : ¥311.2 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Beijing Konruns Pharmaceutical Co Ending Cash Position?

Beijing Konruns Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥311.2 Mil.

Beijing Konruns Pharmaceutical Co's quarterly Ending Cash Position declined from Sep. 2023 (¥341.6 Mil) to Dec. 2023 (¥227.2 Mil) but then increased from Dec. 2023 (¥227.2 Mil) to Mar. 2024 (¥311.2 Mil).

Beijing Konruns Pharmaceutical Co's annual Ending Cash Position declined from Dec. 2021 (¥595.8 Mil) to Dec. 2022 (¥333.3 Mil) and declined from Dec. 2022 (¥333.3 Mil) to Dec. 2023 (¥227.2 Mil).

Beijing Konruns Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Beijing Konruns Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Konruns Pharmaceutical Co Ending Cash Position Chart

Beijing Konruns Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,565.20 1,109.72 595.79 333.33 227.22

Beijing Konruns Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 306.65 179.18 341.59 227.22 311.22

Beijing Konruns Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Beijing Konruns Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=333.328+-106.107
=227.2

Beijing Konruns Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=227.221+83.998
=311.2

Beijing Konruns Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Beijing Konruns Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Konruns Pharmaceutical Co (SHSE:603590) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Konruns Pharmaceutical Co Ltd (SHSE:603590) » Definitions » Ending Cash Position
Comparable Companies
SHSE:688293 SHSE:688238 SHSE:688222 SHSE:688513 SHSE:688197 SZSE:300497 SHSE:600200 SHSE:688046 SHSE:688488 SZSE:300653 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No. 11 Xingsheng South Road, Economic Development Zone, Miyun District, Beijing, CHN
Website
http://www.konruns.cn
Beijing Konruns Pharmaceutical Co Ltd is a Chinese pharmaceutical company. It is engaged in the research and development of innovative drugs, and is oriented to clinical needs.
Executives
Feng Zhang Zheng Director

Beijing Konruns Pharmaceutical Co (SHSE:603590) Headlines

No Headlines